MEDICINA
Département
University of North Carolina at Chapel Hill
Chapel Hill, Estados UnidosPublications en collaboration avec des chercheurs de University of North Carolina at Chapel Hill (23)
2024
-
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
Schizophrenia bulletin, Vol. 50, Núm. 3, pp. 496-512
2023
-
Global disparities in patients with multiple myeloma: a rapid evidence assessment
Blood Cancer Journal, Vol. 13, Núm. 1
2022
2021
-
Co-infections and superinfections complicating COVID-19 in cancer patients: A multicentre, international study
Journal of Infection, Vol. 83, Núm. 3, pp. 306-313
-
Correction to: Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML (Leukemia, (2021), 35, 7, (2119-2124), 10.1038/s41375-021-01125-4)
Leukemia
-
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit
Schizophrenia Research, Vol. 227, pp. 10-17
-
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Blood Cancer Journal, Vol. 11, Núm. 12
-
Randomized phase 2 trial of pevonedistat plus azacitidine versus azacitidine for higher-risk MDS/CMML or low-blast AML
Leukemia
2019
2018
-
Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017
AIDS Research and Human Retroviruses
2016
-
Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry
Journal of the American Heart Association, Vol. 5, Núm. 10
-
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): An open-label, randomised, phase 2 trial
The Lancet, Vol. 387, Núm. 10027, pp. 1551-1560
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557
-
Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction
Blood, Vol. 128, Núm. 9, pp. 1282-1289
-
Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study
Breast Cancer Research and Treatment, Vol. 156, Núm. 1, pp. 81-89
2014
-
Clinical laboratory immunology: An indispensable player in laboratory medicine
American Journal of Clinical Pathology, Vol. 142, Núm. 4, pp. 437-444
-
Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel
Nature Communications, Vol. 5
2013
-
Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis
Hepatology, Vol. 58, Núm. 5, pp. 1742-1756
2012
-
An integrated map of genetic variation from 1,092 human genomes
Nature, Vol. 491, Núm. 7422, pp. 56-65
-
Management of treatment-emergent peripheral neuropathy in multiple myeloma
Leukemia, Vol. 26, Núm. 4, pp. 595-608